KULR vs PGNY vs HIMS vs AEHR

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus 9. 2% for KULR Technology Group, Inc. (KULR). Progyny, Inc. (PGNY) offers the better valuation at 29. 5x trailing P/E (20. 0x forward), making it the more compelling value choice. Analysts rate KULR Technology Group, Inc. (KULR) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Progyny, Inc.

(PGNY) is the cheapest at 29. 5x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Progyny, Inc. is actually cheaper at 20. 0x.

Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +38.

9%, compared to -83. 7% for KULR Technology Group, Inc. (KULR). Over 10 years, the gap is even starker: AEHR returned +75. 0% versus KULR's -75. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Progyny, Inc.

(PGNY) is the lower-risk stock at 0. 79β versus Aehr Test Systems's 4. 86β — meaning AEHR is approximately 519% more volatile than PGNY relative to the S&P 500. On balance sheet safety, KULR Technology Group, Inc. (KULR) carries a lower debt/equity ratio of 3% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus 9. 2% for KULR Technology Group, Inc. (KULR). On earnings-per-share growth, the picture is similar: KULR Technology Group, Inc. grew EPS 53. 0% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Hims & Hers Health, Inc.

(HIMS) is the more profitable company, earning 5. 5% net margin versus -163. 2% for KULR Technology Group, Inc. — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PGNY leads at 6. 6% versus -141. 9% for KULR. At the gross margin level — before operating expenses — HIMS leads at 59. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Progyny, Inc.

(PGNY) trades at 20. 0x forward P/E versus 58. 3x for Hims & Hers Health, Inc. — 38. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PGNY: 60. 8% to $30. 80.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Progyny, Inc.

(PGNY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 79)). KULR Technology Group, Inc. (KULR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PGNY: +48. 8%, KULR: -75. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (KULR (Technology) and PGNY (Healthcare) and HIMS (Healthcare) and AEHR (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: KULR is a small-cap quality compounder stock; PGNY is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; AEHR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.